Pulse Biosciences, Inc.
DE ˙ DB ˙ US74587B1017
21,40 € ↑1,20 (5,94%)
2026-06-04
CENA AKCJI
SecurityDE:6L8 / Pulse Biosciences, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership16,413 shares
Latest Disclosed Value $ 354,357
Creative Planning reports 4.79% decrease in ownership of 6L8 / Pulse Biosciences, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 16,413 shares of Pulse Biosciences, Inc. (DE:6L8) valued at $280,662 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 17,239 shares of Pulse Biosciences, Inc.. This represents a change in shares of -4.79% during the quarter. The current value of the position is $351,238 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F PULSE BIOSCIENCES COM 74587B101 16,413 -826 -4.79 354 50.00 0.0002
2026-02-17 2025-12-31 13F PULSE BIOSCIENCES COM 74587B101 17,239 -2,068 -10.71 237 -30.79 0.0002
2025-11-14 2025-09-30 13F PULSE BIOSCIENCES COM 74587B101 19,307 336 1.77 342 19.23 0.0003
2025-08-08 2025-06-30 13F PULSE BIOSCIENCES COM 74587B101 18,971 3,951 26.30 286 18.67 0.0002
2025-05-15 2025-03-31 13F PULSE BIOSCIENCES COM 74587B101 15,020 -1,010 -6.30 242 -13.62 0.0002
2025-02-14 2024-12-31 13F PULSE BIOSCIENCES COM 74587B101 16,030 -5,880 -26.84 279 -27.34 0.0003
2024-10-11 2024-09-30 13F PULSE BIOSCIENCES COM 74587B101 21,910 11,667 113.90 384 236.84 0.0004
2024-08-15 2024-06-30 13F PULSE BIOSCIENCES COM 74587B101 10,243 10,243 115 0.0001
2017-10-17 2017-09-30 13F PULSE BIOSCIENCES COM 74587B101 0 -300 -100.00 0 -100.00
2017-07-12 2017-06-30 13F PULSE BIOSCIENCES COM 74587B101 300 -175 -36.84 10 0.00 0.0001
2017-04-07 2017-03-31 13F PULSE BIOSCIENCES COM 74587B101 475 475 10 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.